On November 20, 2024, ResMed Inc. (RMD, Financial) held its annual meeting of stockholders, where several significant decisions were made. The stockholders elected eleven nominees to serve on the company's board of directors, ensuring continued leadership and strategic direction for the company.
Additionally, the stockholders ratified the selection of KPMG LLP as ResMed's independent registered public accounting firm for the fiscal year ending June 30, 2025. This decision underscores the company's commitment to maintaining transparency and accuracy in its financial reporting.
Furthermore, the stockholders approved, on an advisory basis, the compensation of ResMed's named executive officers, commonly referred to as the "say-on-pay" vote. This approval reflects the stockholders' support for the company's executive compensation policies and practices.
These outcomes from the annual meeting highlight ResMed's ongoing dedication to governance, financial integrity, and alignment with stockholder interests. For more detailed insights and analysis, visit GuruFocus.com.
Should you invest in ResMed Inc (RMD, Financial) right now? Before you do it, it’s important to understand the business profitability and stock valuations, and find out what the warning signs are about. See the in-depth ResMed Inc (RMD) stock research here.
